.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Aster DM Healthcare merger with Quality Care India Ltd (QCIL) is driving significant financial growth. Specifically, the company reported an 18% year-on-year revenue increase for Q4 FY26, reaching Rs 1,182 crore. Operating EBITDA rose 31% to Rs 253 crore. These results highlight a period of robust expansion and operational efficiency for the healthcare giant.
The consolidation process remains on schedule for completion by the first quarter of FY27. Consequently, the combined entity will operate over 10,600 beds across 28 Indian cities. This scale positions the group among the top three healthcare providers in the country. Furthermore, a pipeline of 4,400 additional beds will support future demand. Shareholders have shown overwhelming support, with 96.68% voting in favor of the vision. This confidence reflects the strategic value of creating an integrated healthcare platform.
Higher patient volumes and improved realisations primarily fueled growth during the quarter. For instance, the average revenue per inpatient (ARPOB) increased by 9% to Rs 1.25 lakh. Total patient volumes also grew by 15%. Regionally, the Kerala and Andhra Pradesh-Telangana clusters were the strongest performers. Moreover, the group's margin improved to 21.7% from 19.3% in the previous year. This improvement stems from strong cost discipline and operating leverage. Investors like Blackstone continue to back the merger as it moves through regulatory approvals.
Q1: When will the merger between Aster DM Healthcare and QCIL be completed?
The company expects to close the merger in the first quarter of FY27, pending final regulatory approvals.
Q2: How many beds will the combined healthcare platform manage?
The combined platform will have over 10,600 beds across 28 cities, with an additional pipeline of 4,400 beds.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Aster DM Healthcare reports 18% Q4 revenue growth as the Quality Care India merger nears completion, creating a top-tier Indian healthcare platform....
4 months ago
A New York City initiative successfully distributed over 48,000 COVID-19 oral antiviral prescriptions through rapid home delivery in 2022. With 92% delivered within 24 hours, the program safeguarded vulnerable and elderly populations, establishing an equitable framework for emergency drug distribution.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
